Provectus Pharmaceuticals Inc. has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic drug for a broad spectrum of cancers, available for select cancer patients.... (Continue reading)
You can subscribe by RSS feed or by e-mail to receive news updates and breaking stories.
Subscribe to RSS feed